eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
4/2010
vol. 2
 
Share:
Share:
abstract:
Original paper

Relapse and duration of survival in patients with serous ovarian cancer

Leszek Gottwald
,
Wiesław Tyliński
,
Sylwia Kaźmierczak-Łukaszewicz
,
Aleksandra Ciałkowska-Rysz

Medycyna Paliatywna 2010; 4: 202–208
Online publish date: 2011/01/05
View full text Get citation
 
Introduction: In patients with ovarian cancer the 5-year survival rate does not exceed 30-40%. The most common histology of the neoplasm is primary serous ovarian cancer.

Aim of study: To assess the survival in patients with relapsed serous ovarian cancer.

Material and methods: The retrospective study conducted in the group of 37 patients aged 25-83 years-old with the relapse of serous ovarian cancer. The follow-up period was 2-71 months (median 20.8 ±17.8). The disease free survival, survival after relapse and overall survival were analyzed. The age, radicality of surgery and staging were analyzed as additional factors.

Results: The disease free survival, survival after relapse and overall survival were: 1–68 months (median 13.6 ±14.8), 0,5-47 months (median 7.2 ±9.5), and 2-71 months (median 20.8 ±17.8) respectively. The correlation between age at diagnosis and both disease free survival and overall survival was observed. The survival after relapse was not connected to the age, radicality of surgery and staging.

Conclusions: The prognosis after relapse in ovarian cancer patients is generally poor. The age at diagnosis can be analyzed as additional predictor of survival in patients with serous ovarian cancer. The survival after relapse in ovarian cancer patients is not dependent from the age, radicality of surgery and staging.
keywords:

ovarian cancer, serous, relapse, treatment, prognosis

FEATURED PRODUCTS
BOOKS
Medycyna Paliatywna
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.